Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2010

Open Access 01-12-2010 | Research article

Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data

Authors: Kristen Migliaccio-Walle, Michael Stokes, Irina Proskorovsky, Dan Popovici-Toma, Wissam El-Hadi

Published in: BMC Cardiovascular Disorders | Issue 1/2010

Login to get access

Abstract

Background

Peripheral arterial disease (PAD) is caused by narrowing of the arteries in the lower extremities. Limited data exist concerning the impact of diffuse vascular disease (DVD) on prognosis and costs. Thus, the objective of this study is to estimate the impact of DVD on morbidity, mortality and costs.

Methods

PAD was identified between 1985 and 1995 and classified by extent of DVD at diagnosis: none (PAD only, reference group), prior myocardial infarction (MI), prior stroke, prior MI and stroke (MI + stroke), prior transient ischemic attack (TIA). Deaths and hospitalizations were identified through December 2000. Hospitalization costs were estimated from the Ontario Case Cost Project, reported in 2002 $CAD. Proportional hazards analyses measured the impact of vascular involvement on mortality while controlling for risk factors (e.g., age, cardiovascular history).

Results

Overall, 16,439 patients with PAD were included; 14.8% had a prior MI, 10.2% a prior stroke, 2.6% prior MI + stroke, 6.4% prior TIA, two-thirds had PAD only. Median survival was shorter for patients with prior MI (9.3 yrs), TIA (6.3), stroke (4.7), and MI+stroke (4.1) versus the reference group (9.9, p < 0.05, all comparisons). Analyses revealed that the death risk was 60% higher in patients with prior stroke and 84% higher for MI + stroke. Atherothrombotic and bleeding event-related costs were $712, $337, $268, and $170 higher per patient/year of follow-up in patients with a history of MI+stroke, MI, stroke, and TIA, respectively.

Conclusion

Patients diagnosed with PAD with DVD have higher risk of poor outcomes and increased costs.
Appendix
Available only for authorised users
Literature
2.
go back to reference Shamoun F, Sural N, Abela G: Peripheral artery disease: therapeutic advances. Expert Rev Cardiovasc Ther. 2008, 6: 539-553. 10.1586/14779072.6.4.539.CrossRefPubMed Shamoun F, Sural N, Abela G: Peripheral artery disease: therapeutic advances. Expert Rev Cardiovasc Ther. 2008, 6: 539-553. 10.1586/14779072.6.4.539.CrossRefPubMed
3.
go back to reference Froehlich JB, Mukherjee D, Avezum A, et al: Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006, 151: 1123-1238. 10.1016/j.ahj.2005.11.005.CrossRefPubMed Froehlich JB, Mukherjee D, Avezum A, et al: Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006, 151: 1123-1238. 10.1016/j.ahj.2005.11.005.CrossRefPubMed
4.
go back to reference Anand RG, Ventura HO, Mehra MR: Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail. 2007, 13: 319-322. 10.1111/j.1527-5299.2007.07344.x.CrossRefPubMed Anand RG, Ventura HO, Mehra MR: Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail. 2007, 13: 319-322. 10.1111/j.1527-5299.2007.07344.x.CrossRefPubMed
5.
go back to reference O'hare AM, Katz R, Shlipak MG, et al: Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006, 113: 388-393. 10.1161/CIRCULATIONAHA.105.570903.CrossRefPubMed O'hare AM, Katz R, Shlipak MG, et al: Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006, 113: 388-393. 10.1161/CIRCULATIONAHA.105.570903.CrossRefPubMed
6.
go back to reference Spencer FA, Lessard D, Doubeni C, et al: Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007, 153: 140-146. 10.1016/j.ahj.2006.09.009.CrossRefPubMed Spencer FA, Lessard D, Doubeni C, et al: Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007, 153: 140-146. 10.1016/j.ahj.2006.09.009.CrossRefPubMed
7.
go back to reference Becker GJ, McClenny TE, Kovacs ME, et al: The importance of increasing public and physician awareness of peripheral artery disease. J Vasc Interv Radiol. 2002, 13: 7-11. 10.1016/S1051-0443(07)60002-5.CrossRefPubMed Becker GJ, McClenny TE, Kovacs ME, et al: The importance of increasing public and physician awareness of peripheral artery disease. J Vasc Interv Radiol. 2002, 13: 7-11. 10.1016/S1051-0443(07)60002-5.CrossRefPubMed
8.
go back to reference Selvin E, Erlinger TP: Prevalence and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004, 110: 738-743. 10.1161/01.CIR.0000137913.26087.F0.CrossRefPubMed Selvin E, Erlinger TP: Prevalence and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004, 110: 738-743. 10.1161/01.CIR.0000137913.26087.F0.CrossRefPubMed
9.
go back to reference Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001, 286: 1317-1324. 10.1001/jama.286.11.1317.CrossRefPubMed Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001, 286: 1317-1324. 10.1001/jama.286.11.1317.CrossRefPubMed
10.
go back to reference Cotter G, Cannon CP, McCabe CH, et al: Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis in Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003, 145: 622-627. 10.1067/mhj.2003.6.CrossRefPubMed Cotter G, Cannon CP, McCabe CH, et al: Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis in Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003, 145: 622-627. 10.1067/mhj.2003.6.CrossRefPubMed
11.
go back to reference Watson K, Watson BD, Pater KS: Peripheral arterial disease: a review of disease awareness and management. Am J Geriatr Pharmacother. 2006, 4: 365-379. 10.1016/j.amjopharm.2006.12.006.CrossRefPubMed Watson K, Watson BD, Pater KS: Peripheral arterial disease: a review of disease awareness and management. Am J Geriatr Pharmacother. 2006, 4: 365-379. 10.1016/j.amjopharm.2006.12.006.CrossRefPubMed
12.
go back to reference Malcolm E, Downey W, Strand LM, et al: Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Marketing Surveillance. 1993, 6: 175-264. Malcolm E, Downey W, Strand LM, et al: Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Marketing Surveillance. 1993, 6: 175-264.
14.
go back to reference Caro JJ, Migliaccio-Walle K, Ishak KJ, et al: The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. BMC Health Serv Res. 2006, 6: 99-10.1186/1472-6963-6-99.CrossRefPubMedPubMedCentral Caro JJ, Migliaccio-Walle K, Ishak KJ, et al: The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. BMC Health Serv Res. 2006, 6: 99-10.1186/1472-6963-6-99.CrossRefPubMedPubMedCentral
15.
go back to reference Margolis J, Barron JJ, Grochulski WD: Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm. 2005, 11: 727-734.PubMed Margolis J, Barron JJ, Grochulski WD: Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm. 2005, 11: 727-734.PubMed
16.
go back to reference Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, New York: Chapman & HallCrossRef Efron B, Tibshirani RJ: An Introduction to the Bootstrap. 1993, New York: Chapman & HallCrossRef
17.
go back to reference Spencer F, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ: Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007, 153: 140-146. 10.1016/j.ahj.2006.09.009.CrossRefPubMed Spencer F, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ: Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007, 153: 140-146. 10.1016/j.ahj.2006.09.009.CrossRefPubMed
18.
Metadata
Title
Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data
Authors
Kristen Migliaccio-Walle
Michael Stokes
Irina Proskorovsky
Dan Popovici-Toma
Wissam El-Hadi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2010
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-10-40

Other articles of this Issue 1/2010

BMC Cardiovascular Disorders 1/2010 Go to the issue